相关实验视频
Updated: May 10, 2026

12:08
Improving IV Insulin Administration in a Community Hospital
Published on: June 11, 2012
18.5K
孕期糖尿病中睡眠促进剂和障碍物:一种定性研究
Lai Tingting1,2, Xie Baoyuan1, Zhao Huifen1
1Nursing Department of the Second Affiliated Hospital of Fujian Medical University Quanzhou, No. 950 Donghai Street, Fengze District, Quanzhou City, Fujian Province, China.
BMC pregnancy and childbirth
|April 30, 2025
概括
妊娠期糖尿病患者的睡眠质量受到疾病影响,怀孕变化,日常行为和支持系统的影响. 解决这些因素可以改善母亲和儿童的健康状况.
科学领域:
- 产科和妇科 产科和妇科
- 睡眠医学 睡眠医学
- 代谢障碍 代谢障碍 代谢障碍
背景情况:
- 睡眠障碍与葡萄糖代谢不良和不良妊娠结果有关.
- 有限的数据存在于妊娠糖尿病 (GDM) 的睡眠经验.
研究的目的:
- 为了确定GDM孕妇的睡眠促进者和障碍.
- 为促进孕产妇和儿童健康的干预提供信息.
主要方法:
- 潜在的定性面试研究.
- 针对18名患有GDM的孕妇进行了有目的的抽样.
- 半结构面试使用Colaizzi的内容分析进行分析.
主要成果:
- 睡眠促进者和障碍物包括疾病影响,与怀孕有关的生理/心理变化,日常行为,环境因素,家庭支持和需要医疗服务.
- 从参与者的经验中出现了五个关键主题.
结论:
- 医疗保健提供者应加强对GDM患者的睡眠卫生教育.
- 针对性干预,如放松训练,是根据已识别的因素推的.
相关概念视频
CNS Depressants: Barbiturates and Benzodiazepines
CNS depressants include drugs from the category of barbiturates and benzodiazepines. They are valuable medications for managing anxiety disorders and insomnia. Barbiturates, once used to induce and maintain sleep, have been replaced mainly by benzodiazepines due to barbiturate's toxicity, tolerance, and overdose risks. They interact with GABAA receptors, leading to sedation at low doses and potentially coma and death at higher doses. Phenobarbital, a long-acting barbiturate, possesses...
Diabetes Mellitus: Type 2 and Gestational
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
Pathophysiology of Diabetes
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...
Hypoglycemia and Glucagon
Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
Diabetes Mellitus: Introduction
Diabetes mellitus consists of chronic metabolic disorders characterized by persistent hyperglycemia. This elevated blood glucose results from defects in insulin secretion, impaired insulin action, or both. Insulin, produced by pancreatic β-cells, is essential for maintaining glucose homeostasis by facilitating cellular glucose uptake for energy or storage. Disruptions in insulin production or function lead to glucose accumulation in the bloodstream, causing the clinical features and long-term...
Hypoglycemia
Hypoglycemia is a blood glucose level below 70 mg/dL. It commonly occurs in individuals using insulin or insulin-secreting drugs, but may also arise in non-diabetic conditions. People with type 1 diabetes are at the highest risk because they depend on exogenous insulin. People with type 2 diabetes are also at risk, especially when treated with insulin or medications such as sulfonylureas, which increase insulin release regardless of blood glucose levels. It develops when insulin levels exceed...

